InsidersTradesSigma
Follow the Acarix AB share price and the full insider trade history of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Acarix AB has published 6 reports. Market capitalisation: €296.9m. The latest transaction was disclosed on 22 September 2025 (Purchase). Among the most active insiders: Aamir Mahmood. The full history is free.
6
Insider Decl.
n/a
Thresholds
€77,965
6 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Fundamental score
Ranked 23,319 of 29,063 companies
30.5
score / 100
Value13
Quality48
FCF yld-13%
Earn yld-17%
EV/EBITDA·
ROE-86%
Gross mgn85%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 September 2025
Declarations6 total
150,000 shares@ €0.02710.0013% mcap100.0% of flowAktieISIN SE0009268717FI:A003S480-1
385,553 shares@ €0.02630.0033% mcap14.9% of flowAktieISIN SE0009268717FI:A003S110-1
588,753 shares@ €0.02470.0048% mcap21.4% of flowAktieISIN SE0009268717FI:A003H027-2
1,382,000 shares@ €0.02040.0093% mcap41.4% of flowAktieISIN SE0009268717FI:A003L497-2
751,549 shares@ €0.02010.0050% mcap22.3% of flowAktieISIN SE0009268717FI:A003M644-2
150,000 shares@ SEK 0.40100.0% of flowTeckningsoptionISIN SE0009268717FI:A001P458-1
6 of 6 declarations
Acerca de Acarix AB
Acarix AB es una empresa centrada en el desarrollo de soluciones de diagnóstico para enfermedades cardiovasculares. Cotiza en la Bolsa de Estocolmo bajo el símbolo XSTO.